A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)

NCT01351792 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Foster® 100/6 µg/unit dose
DRUG: Symbicort® Turbohaler® 200/6 μg/actuation

Sponsor

Chiesi Farmaceutici S.p.A.